semaglutide weight loss houston tx Medical Semaglutide Weight Loss Treatment in

Patients should disclose a history of pancreatitis, gallbladder disease, severe gastrointestinal disease, kidney disease or dehydration risk, use of diabetes medications such as insulin or sulfonylureas, pregnancy or plans for pregnancy, and any personal or family history of medullary thyroid carcinoma or MEN2

High quality product

Weight loss has long been a cornerstone of preventive health yet for many people, traditional strategies like diet and exercise alone don't deliver lasting results

2 The findings from the OASIS 4 trial, published in the New England Journal of Medicine in September 2025, led the FDA to approve the Wegovy pill in December 2025, making it the first oral GLP-1 medication approved specifically for weight loss